An inside and independent look at the Golden State's $12 billion stem cell research program, how it works, who wins and who loses, its conflicts of interest and its changing priorities.
Excellent, dogged news coverage of California's multibillion-dollar stem cell agency
Cofounder and CEO of Serve Robotics (Nasdaq: SERV). Building a future where millions of autonomous robots power everyday life. Writing about AI, robotics, infrastructure, and what it takes to responsibly scale intelligent machines.